Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.
about
Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromesEstimating tissue iron burden: current status and future prospects.Risk of erectile dysfunction in transfusion-naive thalassemia men: a nationwide population-based retrospective cohort studyIron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.Deferasirox for managing iron overload in people with thalassaemia.Prevalence of low bone mass among adolescents with nontransfusion-dependent hemoglobin E/β-thalassemia and its relationship with anemia severity.Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?How we manage iron overload in sickle cell patients.Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.Serum ferritin values between 300 and 800 ng/mL in nontransfusion-dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable.Proton pump inhibitors use suppresses iron absorption in congenital dyserythropoietic anemia.Iron overload in patients with rare hereditary hemolytic anemia: Evidence-based suggestion on whom and how to screen
P2860
Q26771519-6AAAE181-3B4F-44D9-82AD-FCC7D7155D4CQ35793545-31D0C5AE-1501-46F1-A59E-35F6150F5F61Q36009153-E9081854-BD0C-4C7D-9D15-3E4488208F2CQ37595987-F5E286E0-7F99-46AD-A4CD-D1D41E18E2F8Q38624033-70CD27B1-33A7-47C8-AD08-CEFCBA3CAB55Q38627948-C25A4A66-215C-4BB5-ABAB-66D023F4FF50Q38836181-4E0C241C-615D-4DF1-B999-62DD14974DBAQ39179372-A99821CE-B0AF-49C7-A73F-2E07F6C3F197Q43909780-42A5CF57-4838-4017-BF05-8A2BE547C1E9Q47771973-F90B9658-A47C-450B-8569-F083C6163E45Q48096215-C7CCE68A-3A87-46A0-866F-80EFC2B25614Q51269698-F254D8C3-8EB0-4669-8707-021CAC7DE2C5Q58697809-42DA7ECB-F001-4F7C-AF53-FB3AA634BB6B
P2860
Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Defining serum ferritin thresh ...... fusion-dependent thalassaemia.
@en
type
label
Defining serum ferritin thresh ...... fusion-dependent thalassaemia.
@en
prefLabel
Defining serum ferritin thresh ...... fusion-dependent thalassaemia.
@en
P2093
P2860
P50
P356
P1476
Defining serum ferritin thresh ...... sfusion-dependent thalassaemia
@en
P2093
Ali T Taher
Antonis Kattamis
Noppadol Siritanaratkul
Pranee Sutcharitchan
Suporn Chuncharunee
Vip Viprakasit
Zeynep Karakas
P2860
P304
P356
10.1111/BJH.13119
P407
P577
2014-09-12T00:00:00Z